BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Selecta Biosciences Announces Important Additions to Senior Leadership Team

  The company announced two additions to its management team today.

  October 26, 2017

   · 

  6 min read
• Business

  BioMed X Announces Biomedical Research Collaboration with Janssen

  BioMed X announced today a collaboration agreement with Janssen Research & Development to foster early-stage preclinical biomedical research and development projects.

  October 26, 2017

   · 

  2 min read
• Business

  Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7

  Management will host a conference call to discuss the results.

  October 26, 2017

   · 

  1 min read
• Drug Development

  Tocagen to Accelerate Toca 511 & Toca FC Development Into Pivotal Phase III Trial

  Tocagen has updated the protocol of the ongoing clinical trial of Toca 511 & Toca FC for the treatment of recurrent high-grade glioma patients.

  October 26, 2017

   · 

  5 min read
• Business

  Cryoport to Report Third Quarter 2017 Financial Results on November 2nd, 2017

  CryoPort today announced that the Company will report financial results for the third quarter ended September 30, 2017 on Thursday, November 2, 2017 after U.S. financial markets close.

  October 26, 2017

   · 

  3 min read
• Business

  Tandem Diabetes Care Reports Third Quarter 2017 Financial Results

  Tandem Diabetes Care, Inc., a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today reported its financial results for the quarter ended September 30, 2017.

  October 26, 2017

   · 

  17 min read
• Business

  Apollo Endosurgery, Inc. Reports Third Quarter 2017 Results

  Apollo Endosurgery, Inc., a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the third quarter ended September 30, 2017.

  October 26, 2017

   · 

  15 min read
• Evonik Expands Capacities for Hydrogen Peroxide in Europe

  Evonik shapes its hydrogen peroxide business more customer-oriented and reacts to the increased need of active oxygens.

  October 26, 2017

   · 

  1 min read
• FDA

  Paraflu Assay Now FDA Cleared on Hologic’s New Panther Fusion System

  Hologic announced today that it has received 510(k) clearance from the FDA for its Panther Fusion Paraflu assay, a multiplexed assay which runs on the new Panther Fusion system.

  October 26, 2017

   · 

  3 min read
• Genetown

  Catabasis Pharmaceuticals Announces Upcoming Presentation on CAT-5571 As a Potential Treatment for Cystic Fibrosis at the 31st Annual North American Cystic Fibrosis Conference

  Catabasis Pharmaceuticals today announced that CAT-5571, which restores host defense by activating autophagy, will be presented in a poster at the 31st Annual North American Cystic Fibrosis Conference (NACFC).

  October 26, 2017

   · 

  3 min read